Table 3.
Pairwise comparisons of the association between the change in proteinuria status and the risk of incident hypertension.
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| HR (95% CI) | p-Value | HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
| Proteinuria-resolved vs. Proteinuria-free (reference) | 1.19 (1.15, 1.23) | <0.001 | 1.17 (1.13, 1.21) | <0.001 | 1.17 (1.13, 1.21) | <0.001 |
| Proteinuria-developed vs. Proteinuria-free (reference) | 1.31 (1.27, 1.36) | <0.001 | 1.31 (1.27, 1.35) | <0.001 | 1.31 (1.26, 1.35) | <0.001 |
| Proteinuria-resolved vs. Chronic proteinuria (reference) | 0.46 (0.43, 0.50) | <0.001 | 0.58 (0.53, 0.63) | <0.001 | 0.58 (0.53, 0.63) | <0.001 |
| Proteinuria-developed vs. Chronic proteinuria (reference) | 0.52 (0.48, 0.56) | <0.001 | 0.65 (0.59, 0.70) | <0.001 | 0.65 (0.60, 0.71) | <0.001 |
Model 1 was adjusted for age and sex. Model 2 was adjusted for age, sex, body mass index, household income, smoking, alcohol consumption, physical activity, history of diabetes mellitus, dyslipidemia, atrial fibrillation, cancer, and renal disease. Model 3 was adjusted for age, sex, body mass index, household income, smoking, alcohol consumption, physical activity, history of diabetes mellitus, dyslipidemia, atrial fibrillation, cancer, renal disease, and Charlson Comorbidity Index. HR, hazard ratio; CI, confidence interval.